Effective use of caposide in outpatient treatment of cardiac failure

Aim. To evaluate results of long-term outpatient use of caposide in patient s with cardiac failure. Material and methods. 74 patients (59 males and 15 females aged 40-76 years ) with chronic cardiac failure (CCF) received caposide in individual doses. CCF was caused by ischemic heart disease (IHD) and dilated cardiomyopathy in 65 and 9 patients, respectively. The treatment effect was assessed by ch anges in clinical symptoms, quality of life and physical activity. Results. Clinical symptoms, functional class of IHD, exercise tolerance and quality of life improved. Serious side effects were absent. Conclusion. Caposide can be considered as first-line therapy in outpatient treatment of patients with CCF of different severity as monotherapy and adj uvant in combined treatment.